What Is MBX Biosciences, Inc. (MBX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, MBX Biosciences, Inc.'s intrinsic value is estimated at $26.28, suggesting the stock is overvalued at its current price of $60.68. With 7 out of 7 models flagging downside (-56.7% average return), the market may be pricing in unsustainable growth. The most optimistic model, Sentiment SOTP, places fair value at $52.84 (-12.9%), while ML-RIV — the most conservative — estimates $4.33 (-92.9%). This +79.9% gap reflects genuine analytical uncertainty about MBX Biosciences, Inc.'s intrinsic worth.
What Do the Models Say About MBX?
7 of 13 models are currently active for MBX. All 7 active models suggest the stock trades above fair value. The Bayesian DCF estimates MBX's intrinsic value at $13.21, implying -78.2% downside from the current price. See which stocks rank higher →
How Does MBX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, MBX ranks #277 by Quality of Company score. CirclFi's QOC score of 4.5/10 evaluates 32 fundamental signals. A score of 4.5 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Within the Pharmaceutical Preparations space, MBX Biosciences, Inc. competes in an environment where R&D productivity ratio often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is MBX a Value Trap?
CirclFi's Value Trap algorithm assigns MBX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for MBX Biosciences, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, MBX Biosciences, Inc.'s fundamental quality profile registers 4.5/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +79.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MBX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MBX's 7 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad